NCT07196644
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07196644
Title A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: senior | child | adult
Covered Countries USA | ISR

Facility Status City State Zip Country Details
Valkyrie Clinical Trials /ID# 275547 RECRUITING Los Angeles California 90067 United States Details
START Midwest /ID# 276603 RECRUITING Grand Rapids Michigan 49546 United States Details
Duke Cancer Institute /ID# 275604 RECRUITING Durham North Carolina 27710 United States Details
South Texas Accelerated Research Therapeutics (START) /ID# 276608 RECRUITING San Antonio Texas 78229 United States Details
Start Mountain Region /ID# 276607 RECRUITING West Valley City Utah 84119 United States Details
The Chaim Sheba Medical Center /ID# 274342 RECRUITING Ramat Gan Tel Aviv 5265601 Israel Details
Tel Aviv Sourasky Medical Center /ID# 274344 RECRUITING Tel Aviv Tel Aviv 6423906 Israel Details
Hadassah Medical Center-Hebrew University /ID# 274343 RECRUITING Jerusalem 91120 Israel Details
Rabin Medical Center /ID# 274341 RECRUITING Petah Tikva 4941492 Israel Details
Nagoya University Hospital /ID# 276336 RECRUITING Nagoya Aichi-ken 466-8560 Japan Details
Hokkaido University Hospital /ID# 276333 RECRUITING Sapporo Hokkaido 060-8648 Japan Details
Okayama University Hospital /ID# 276299 RECRUITING Okayama Okayama-ken 700-8558 Japan Details
National Cancer Center Hospital /ID# 276297 RECRUITING Chuo-Ku Tokyo 104-0045 Japan Details
Samsung Medical Center /ID# 275705 RECRUITING Seoul Seoul Teugbyeolsi 06351 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field